Search the Newsreel

You could be owed money in Equifax's $2.2M settlement

Equifax has agreed to a $2.2 million class action settlement to resolve claims that duplicate collection accounts appeared on some consumers' credit reports in 2022, potentially lowering credit scores and affecting credit applications. An estimated 37,000 consumers may be eligible for cash payments of …

Medifast Number of Employees 2026 | Employee Count & Headcount Data

Medifast, Inc. (MED) had approximately 381 employees worldwide as of March 2026, according to Revelio Labs data. This represents a 12.3% decline from 434 employees in 2023. The company, headquartered in Baltimore, Maryland, is actively hiring with 12 job postings in 2026, though this …

Is Equifax Inc (EFX) a Bargain After 5.8% Drop? GF Value Says Un

Equifax Inc. (EFX) shares dropped by 5.8% to $176.13, yet GuruFocus's GF Value™ identifies it as significantly undervalued by 38.9% compared to its estimate of $288.24. Despite a strong GF Score™ of 75/100, indicating above-average quality and profitability, insider selling of $7.6M in the …

Equifax Number of Employees 2026 | Employee Count & Headcount Data

Equifax (EFX) reported approximately 15,372 employees worldwide as of March 2026, marking a 7.4% growth from 2023. The company is actively hiring with 2,025 active job postings, and its workforce is primarily concentrated in North America, with functional groups focused on Finance and Operations, …

Equifax (EFX) Looks Attractive Defying Mortgage Weakness and AI Fears

Investment management company Vulcan Value Partners recently released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. Vulcan Value Partners prioritizes long-term returns and lower risk over short-term performance. In the quarter, the Large Cap Composite (Net) returned 9.5%, …

Medifast Inc (MED) Institutional Confidence

Medifast Inc (MED) has an institutional shareholding score of 7.00, placing it 24th out of 93 in the Food & Tobacco industry. The institutional shareholding proportion is 83.21%, a 2.48% decrease quarter-over-quarter. James Simons is the largest institutional shareholder, holding 7.55% of outstanding shares.

Capital Market Earnings Crash Out

In this episode of Motley Fool Hidden Gems Investing, Motley Fool contributors Tyler Crowe, Matt Frankel, and Lou Whiteman discuss: Equifax's and MSCI's earnings and stock reactions. How AI costs are eating into profits. Halliburton's comments on the oil market. Mailbag: Best banking ETF …

Equifax (EFX) Is Up 9.7% After Leveraging Up To Fund Buybacks And Guide Double-Digit Growth – Has The Bull Case Changed?

Equifax (EFX) recently reported its Q2 2026 results, showing higher sales but lower net income, while also issuing strong Q3 guidance. The company leveraged new debt to fund a substantial share repurchase program, signaling confidence in future growth despite increased liabilities. This strategy raises …

Equifax Inc (EFX) Financial Health: Profitability & Balance Sheet Analysis

Equifax Inc (EFX) has a stable financial status with an average operating efficiency, ranking 72 out of 159 in its industry. The company reported a quarterly revenue of $1.70 billion, marking a 10.61% year-over-year increase, and a net profit increase of 3.87% year-over-year. Its …

Medifast Inc (MED) Q1 2024 Earnings Report - Results, Call & Slides

Medifast Inc (MED) reported its Q1 2024 earnings, missing analyst expectations for EPS with an actual EPS of $0.66 against a consensus of $0.80, a miss of -$0.14. However, the company beat revenue estimates, reporting $174.74M against an expected $173.45M. The revenue for Q1 …

Equifax prices $1.0B of senior notes at 5.00% and 5.65% to refinance commercial paper

Equifax (EFX) has priced $1.0 billion in senior notes, consisting of $500 million at 5.000% due 2029 and $500 million at 5.650% due 2033. The company expects to receive approximately $990.5 million in net proceeds, which will be used to repay borrowings under its …

Equifax (NYSE: EFX) raises $990.5M via 2029 and 2033 senior notes

Equifax Inc. has successfully raised approximately $990.5 million by issuing senior notes due in 2029 and 2033. These proceeds are intended to repay borrowings under the company's existing commercial paper program. The transaction involves $500 million in 5.000% Senior Notes due 2029 and $500 …

BlackRock discloses 2.9% Medifast (NYSE: MED) ownership stake

BlackRock, Inc. has reported a beneficial ownership stake of 2.9% in Medifast, Inc. (NYSE: MED), totaling 327,404 shares as of June 30, 2026. The filing, an amended passive investment disclosure (SCHEDULE 13G/A), indicates that BlackRock holds sole voting and dispositive power over these shares, …

How Equifax Is Using AI and Mortgage Demand to Drive Its Next Growth

Equifax is leveraging artificial intelligence, increased mortgage scoring adoption, and strategic international acquisitions to fuel its future growth. The company aims to expand its margins through AI-driven efficiency, build on strong U.S. mortgage revenue, and widen its global footprint, notably with the acquisition of …

Is Equifax Stock Attractive After Its Steep One-Year Price Decline?

Equifax (EFX) stock has fallen 22.7% in the past year, prompting questions about its current value. While revenue and adjusted earnings growth remain strong, valuation, estimate revisions, and momentum signals do not yet make the stock an obvious bargain. The company's cash flow is …

Medifast Stock to Post Q2 Earnings: What Investors Should Know

Medifast (MED) is set to announce its Q2 fiscal 2026 earnings on August 3, with analysts projecting a significant decline in revenue and a loss per share, mainly due to the impact of GLP-1 medications on the weight-loss market. Despite challenges from reduced demand …

Equifax Survey: Three in Four HR Professionals Report Challenges with Fabricated and Misleading Candidate Information

A recent Equifax HR Trends Survey found that 73% of HR professionals struggle with fabricated candidate information, with half citing employment history as the main issue. While 78% report AI improves hiring efficiency, 36% also note it reduces confidence in hiring decisions due to …

Medifast Inc (MED) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Medifast Inc (MED), highlighting its current risk score of 5.66, ranking 46th in the Food & Tobacco industry. Key metrics such as the company's beta value of 0.65, maximum drawdown, and volatility are detailed. The analysis suggests …

2 Reasons to Sell EFX and 1 Stock to Buy Instead

2 Reasons to Sell EFX and 1 Stock to Buy Instead Over the past six months, Equifax's stock price fell to $177.62. Shareholders have lost 13.5% of their capital, which is disappointing considering the S&P 500 has climbed by 6.3%. This was partly due …

Equifax Insider Sold Shares Worth $6,506,255, According to a Recent SEC Filing

An insider at Equifax (NYSE: EFX) has sold shares valued at $6,506,255 according to a recent SEC filing. The article was published on July 28, 2026, at 04:26 PM EDT, according to MT Newswires. Equifax specializes in providing information services to individuals and businesses …

Medifast Inc (MED) Cash Flow

This article provides a detailed cash flow statement for Medifast Inc (MED), including operating, investing, and financing cash flows presented quarterly and annually. It highlights key financial figures such as operating cash flow of $6.86 million in FY2025 and capital expenditures of $5.61 million …

Equifax Inc (EFX) Valuation: PE, PB & Fair Value Analysis

This article analyzes the valuation of Equifax Inc (EFX), noting its current valuation score of 8.21, ranking 100 out of 160 in the Professional & Commercial Services industry. The P/E ratio is 31.02, which is significantly below its recent high and slightly above its …

iFabric Corp. Revenue Breakdown – TSX:IFA

(EFX) and the Role of Price-Sensitive Allocations

This article provides an in-depth AI-generated analysis of Equifax Inc. (NYSE: EFX), highlighting stable neutral readings in shorter horizons and testing resistance. It details three institutional trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels. The analysis also includes …

Medifast (MED) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Wall Street expects a year-over-year decline in earnings on lower revenues when Medifast (MED) reports results for the quarter ended June 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock …

Unlocking Equifax (EFX) International Revenues: Trends, Surprises, and Prospects

Have you looked into how Equifax (EFX) performed internationally during the quarter ending June 2026? Considering the widespread global presence of this credit reporting company, examining the trends in international revenues is essential for assessing its financial resilience and prospects for growth. The global …

Medifast (MED) to Release Quarterly Earnings on Monday

Medifast (MED) is scheduled to release its Q2 2026 earnings after market close on Monday, August 3rd, with analysts anticipating a loss of $0.67 per share on $72.7 million in revenue. The company had a stronger-than-expected Q1, reporting a $0.19 per-share loss against a …

Medifast Inc (MED) Income Statement

This article provides Medifast Inc's (MED) income statement data, presenting both quarterly and annual financial metrics. It includes details such as total revenue, cost of revenue, operating expenses, operating profit, net non-operating interest, income before tax, income tax, income after tax, and earnings per …

Medifast Inc (MED) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Medifast Inc (MED), highlighting its major shareholders and institutional holdings. It provides a breakdown of proportional ownership by investment advisors, hedge funds, and individual investors, along with a historical view of institutional shareholding and recent changes in …

MED|Medifast Inc|Price:9.680|Chg%:+0.220

Medifast Inc. (MED) is a health and wellness company focusing on its OPTAVIA lifestyle solution, which includes coaching, community, tailored nutrition, and healthy habits to support weight management. The company also collaborates with LifeMD, Inc. to provide access to GLP-1 medications where appropriate. Its …

Medifast Inc (MED) Q1 2025 Earnings Report - Results, Call & Slides

Medifast Inc (MED) has released its Q1 2025 earnings report, revealing an actual EPS of -$0.58, significantly beating the consensus EPS of -$4.36. However, the company's actual revenue of $2.02 billion missed the expected revenue of $2.03 billion, marking a YoY revenue growth decrease …

Equifax Q3 Outlook Pressured by Contract Signing Delays, Oppenheimer Says

Oppenheimer maintained an Outperform rating on Equifax (EFX) but lowered its price target due to anticipated Q3 2026 revenue and EBITDA pressure. The revision is attributed to longer than expected delays in contract signings and a softer mortgage market affecting the company's Workforce Solutions …

A Quick Look at Today's Ratings for Equifax(EFX.US), With a Forecast Between $179 to $235

This article provides an overview of recent analyst ratings for Equifax (EFX.US), highlighting a consensus price target range of $179 to $235. It details the latest analyst actions, including upgrades and reiterations, reflecting varied perspectives on the company's stock performance. The report offers a …

Enerflex Ltd. (EFX) Q4 2025 Earnings Report - Results, Call & Slides

Enerflex Ltd. (TSE:EFX) reported its Q4 2025 earnings, missing EPS estimates at -C$0.66 against a consensus of C$0.19, but beating revenue expectations with C$874.26M. The company highlighted strong year-over-year revenue growth, a significant Engineered Systems backlog, record free cash flow, improved ROCE, and reduced …

EQUIFAX INC. : WELLS FARGO CUTS TARGET PRICE TO $212 FROM $220

Wells Fargo has lowered its target price for Equifax Inc. (NYSE: EFX) shares to $212 from $220. This adjustment reflects a revised outlook on the company's valuation by the financial institution.

Equifax (EFX) Q2 2026 earnings summary

Equifax (EFX) reported a strong Q2 2026, with revenue growing 11% year-over-year to $1.7B and adjusted EPS rising 13% to $2.25, exceeding guidance. The company announced the acquisition of Círculo de Crédito for $750M, doubled its AI-driven cost reduction target to $150M, and returned …